The New Amorphical Manufacturing Facility

Amorphical is currently building a 3,000 square meter (32,000 square feet) pharmaceutical-grade facility to increase the manufacturing capacity for DENSITY and its other ACC products.

The first phase is scheduled for completion in 2015. The second phase will be completed when increasing market demand requires additional production capacity. The cGMP facility is being designed and built to comply with the highest pharmaceutical manufacturing standards of the FDA, EMA, and Israel’s Ministry of Health.